1. Home
  2. INDP vs TRNR Comparison

INDP vs TRNR Comparison

Compare INDP & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • TRNR
  • Stock Information
  • Founded
  • INDP 2000
  • TRNR 2017
  • Country
  • INDP United States
  • TRNR United States
  • Employees
  • INDP N/A
  • TRNR N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • TRNR Consumer Electronics/Appliances
  • Sector
  • INDP Health Care
  • TRNR Technology
  • Exchange
  • INDP Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • INDP 7.4M
  • TRNR 6.8M
  • IPO Year
  • INDP N/A
  • TRNR 2023
  • Fundamental
  • Price
  • INDP $0.45
  • TRNR $0.94
  • Analyst Decision
  • INDP Strong Buy
  • TRNR
  • Analyst Count
  • INDP 2
  • TRNR 0
  • Target Price
  • INDP $8.50
  • TRNR N/A
  • AVG Volume (30 Days)
  • INDP 43.0K
  • TRNR 2.0M
  • Earning Date
  • INDP 05-14-2025
  • TRNR 05-19-2025
  • Dividend Yield
  • INDP N/A
  • TRNR N/A
  • EPS Growth
  • INDP N/A
  • TRNR N/A
  • EPS
  • INDP N/A
  • TRNR N/A
  • Revenue
  • INDP N/A
  • TRNR $5,380,000.00
  • Revenue This Year
  • INDP N/A
  • TRNR $355.02
  • Revenue Next Year
  • INDP N/A
  • TRNR N/A
  • P/E Ratio
  • INDP N/A
  • TRNR N/A
  • Revenue Growth
  • INDP N/A
  • TRNR 459.25
  • 52 Week Low
  • INDP $0.43
  • TRNR $0.62
  • 52 Week High
  • INDP $3.10
  • TRNR $996.00
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.18
  • TRNR 55.51
  • Support Level
  • INDP $0.36
  • TRNR $0.56
  • Resistance Level
  • INDP $0.48
  • TRNR $1.08
  • Average True Range (ATR)
  • INDP 0.05
  • TRNR 0.10
  • MACD
  • INDP 0.01
  • TRNR 0.06
  • Stochastic Oscillator
  • INDP 59.80
  • TRNR 72.29

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: